ClinConnect ClinConnect Logo
Search / Trial NCT06771739

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Launched by FRED HUTCHINSON CANCER CENTER · Jan 8, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

The PAYMENT Trial is a clinical study designed to see if giving early-stage cancer patients cash payments can help them handle the financial stress that often comes with a cancer diagnosis. Many patients face high medical bills and may struggle to pay for everyday expenses like food and rent, which can lead to worse health outcomes. This trial will provide participants with a cash card each month that they can use for any expenses they choose, helping them focus on their treatment without worrying as much about money.

To be eligible for this trial, participants need to be at least 18 years old, understand English, and be newly diagnosed with an early-stage solid tumor that is being treated with the aim of curing it. They should also be patients at specific PeaceHealth locations and show signs of financial stress. The trial will not accept individuals who are on Medicaid or enrolled in hospice care. If you join the study, you can expect to receive monthly cash support, which may help improve your overall quality of life while you undergo cancer treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \>= 18
  • Ability to understand English
  • Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants
  • Within 90 days of a non-metastatic or early-stage solid tumor receiving or rescheduled to receive treatment in the neoadjuvant, adjuvant or definitive setting for curative intent. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
  • Current cancer patient at PeaceHealth (Southwest Medical Center or St. Joes)
  • Not current Medicaid enrollee
  • Not enrolled in hospice
  • Screens positive for financial fragility

About Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center is a leading nonprofit research institution dedicated to the pursuit of innovative cancer treatments and prevention strategies. Established in Seattle, Washington, the center is renowned for its pioneering work in hematopoietic cell transplantation and its commitment to advancing cancer research through collaborative clinical trials. By integrating cutting-edge science with compassionate patient care, Fred Hutchinson Cancer Center aims to improve outcomes for patients while fostering a multidisciplinary approach to tackling complex cancer challenges. With a strong emphasis on translating research findings into clinical applications, the center is at the forefront of developing novel therapies that offer hope to patients worldwide.

Locations

Vancouver, Washington, United States

Bellingham, Washington, United States

Patients applied

0 patients applied

Trial Officials

Veena Shankaran, MD

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported